The proposed merger of Beth Israel Deaconess Medical Center, Lahey Health System, New England Baptist Hospital, Mount Auburn Hospital, and Anna Jaques Hospital had the potential to transform healthcare throughout the greater Boston area. When it became the subject of intense regulatory scrutiny, the hospital groups and other parties to the merger turned to Goodwin’s Antitrust and Competition practice to handle the exhaustive federal and state investigations.
Financing for the Future
When Akili Interactive Labs, Inc. looked to raise over $65 million in a Series C Preferred Stock financing (led by Temasek with new and existing investors including Baillie Gifford, Amgen Ventures, M Ventures, JAZZ Venture Partners, Canepa Advanced Healthcare Fund and Brooklands Capital Strategies), Akili turned to Goodwin to guide it through a financing that could help advance Akili’s digital medicine platform in the quest to treat neurological and psychiatric disorders.
Investing in Hope
When Goodwin client Surface Oncology Inc. went public with a $108 million initial public offering (while also selling $11.5 million in shares in a concurrent private placement to Novartis Institutes for Biomedical Research), Surface relied on Goodwin’s expertise to guide the company in closing the $119.5 million aggregate financing.